Sanofi shares CAC 40 rally, Digi Mart USA News (Paris): The pharmaceutical company extended its sharp rebound of recent weeks in a Paris market trending higher. A very favorable analyst rating, published Monday, accompanied the move and renewed investor interest in the stock.
The stock gained 2.41 percent to 85.76 euros and held the first place in the CAC 40, an index that rose 0.36 percent. Intraday, Sanofi broke above its former resistance at 84.53 euros, which now serves as its support.
The relative strength index (RSI) stood at 80, signaling an overbought configuration.
The move extends a series of gains. The stock is up 7.55 percent over one week and 20.91 percent over one month, after touching a multi-year low in early October.
The next technical level for Sanofi shares is resistance at 89.89 euros. The group raised its 2026 targets on October 30, after a third quarter that rose 14.3 percent, driven by Dupixent.
Exane BNP Paribas raised its price target from 79 euros to 102 euros and upgraded its rating from neutral to outperform, implying upside potential of about 19 percent relative to the current share price. The move follows a target increase by Barclays earlier in November.
Based on expected earnings per share, according to the consensus of surveyed analysts, the stock trades at about 9.6 times current-year earnings and 9.2 times next-year earnings. The analyst consensus will be watched in the coming days.
On the technical side, the price remains well above its moving averages, sitting 11.75 percent above the 20-day moving average (MM20) and 11.72 percent above the 200-day moving average (MM200).
